Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Iridex (IRIX) over the last 15 years, with Q3 2025 value amounting to -$77000.0.

  • Iridex's Gains from Investment Securities rose 4900.66% to -$77000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$14000.0, marking a year-over-year decrease of 11891.89%. This contributed to the annual value of $58000.0 for FY2024, which is 8641.69% down from last year.
  • As of Q3 2025, Iridex's Gains from Investment Securities stood at -$77000.0, which was up 4900.66% from -$25000.0 recorded in Q2 2025.
  • In the past 5 years, Iridex's Gains from Investment Securities registered a high of $708000.0 during Q4 2022, and its lowest value of -$151000.0 during Q3 2024.
  • Its 5-year average for Gains from Investment Securities is $118764.7, with a median of $96000.0 in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 38181.82% in 2021, then skyrocketed by 110000.0% in 2023.
  • Iridex's Gains from Investment Securities (Quarter) stood at -$53000.0 in 2021, then skyrocketed by 301.89% to $107000.0 in 2022, then surged by 86.92% to $200000.0 in 2023, then decreased by 8.0% to $184000.0 in 2024, then crashed by 141.85% to -$77000.0 in 2025.
  • Its Gains from Investment Securities was -$77000.0 in Q3 2025, compared to -$25000.0 in Q2 2025 and -$96000.0 in Q1 2025.